InsidersTradesSigma
Follow the Imugene Limited stock price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, Imugene Limited has logged 3 insider filings. Market capitalisation: €41.3m. The latest transaction was disclosed on 31 July 2026 (Other). Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Imugene Limited is a biopharmaceutical company focused on developing immunotherapeutic treatments for cancer. It is listed on the Australian Securities Exchange under the ticker IMU.